Refractive Results With EyeCryl Phakic Toric Intraocular Lens Implantation in a Hospital in Medina, Saudi Arabia: A Retrospective Study.

OBJECTIVES

To evaluate the efficacy, safety, and stability of EyeCryl Phakic intraocular lens (IOL) implantation.

METHODOLOGY

This retrospective study was conducted in Maghrabi Hospital in Medina to review 31 patients who underwent posterior chamber phakic IOL (EyeCryl Phakic IOL) for surgical correction of myopia or astigmatism. The data were collected from patient medical records after obtaining their consents.

RESULTS

Our findings demonstrated the efficacy of a toric implantable collamer lens (ICL) for the treatment of myopic astigmatism, with a significant change in all eye measures (sphericity, axis, and cylinder) after IOL implantation for study participants in both right and left eyes. There were no intraoperative complications observed among the studied patients; however, one case required ICL repositioning due to spontaneous axis rotation. The majority of cases showed no postoperative complications except one case complaint of steroid-induced glaucoma. In this study, we observed no significant changes regarding endothelial cell loss.

CONCLUSION

In summary, EyeCryl Phakic IOL implantation may be safe and effective for myopic astigmatism patients. It improved the visual performance of most of the studied participants without detecting serious complications. Studies with longer follow-ups are needed to observe other complications and ensure the safety of the procedure.